On-Treatment Adverse Events Reported in at Least 10% of Mipomersen Patients.

aThis patient also had another acute myocardial infarction occurring during post-treatment follow-up, which was fatal.bEvents not related to study drug in the opinion of the investigator.c3 of 4 events of angina pectoris in the mipomersen group were considered drug-related. The 4th event and the event in the placebo group were considered not drug-related.dConsidered possibly drug-related.